文献速递消化道肿瘤与早癌消化内镜

早发性结直肠癌患者胚系基因检测的种族差异

Racial and Ethnic Disparities in Germline Genetic Testing of Patients With Young-Onset Colorectal Cancer.
PubMed 文献 · Clin Gastroenterol Hepatol · 2020-12-24

本研究纳入2009-2017年达拉斯两个医疗系统385例18-49岁结直肠癌患者,评估遗传咨询转诊、出席及胚系检测的种族差异。黑人患者转诊率和出席率均低于白人和西班牙裔,且意义不明变异多发生于少数族裔。结论强调应普及基因检测以缩小差异。

要点

  • 接受检测者中27.0%携带致病/可能致病变异,84.8%的意义不明变异见于少数族裔。

核心结论

  • 在早发性结直肠癌患者中观察到胚系基因检测转诊和接受方面的种族/民族差异,强调普及基因检测的重要性。

研究设计与样本

  • 回顾性队列研究,纳入2009-2017年达拉斯两个医疗系统中18-49岁确诊结直肠癌的385例患者。

主要发现

  • 141例接受基因检测的患者中,38例(27.0%)携带致病或可能致病变异。
  • 33例(23.4%)携带意义不明变异,其中84.8%发生于少数族裔。
  • 错配修复蛋白免疫组化检测率76.9%,不同种族间无差异。

临床怎么用

  • 临床应关注早发性结直肠癌患者遗传咨询转诊和基因检测中的种族差异,推动普及检测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Up to 20% of younger patients (age <50 years) diagnosed with colorectal cancer (CRC) have germline mutations in cancer susceptibility genes. Germline genetic testing may guide clinical management and facilitate earlier intervention in affected relatives. Few studies have characterized differences in genetic testing by race/ethnicity. METHODS: We identified young adults (age 18-49 years) diagnosed with CRC between 2009 and 2017 in 2 health systems in Dallas, TX. We evaluated referral to genetic counseling, attendance at genetic counseling appointments, and receipt of germline genetic testing by race/ethnicity. RESULTS: Of 385 patients with young-onset CRC (median age at diagnosis 44.4 years), 176 (45.7%) were Hispanic, 98 (25.4%) non-Hispanic Black, and 111 (28.8%) non-Hispanic White. Most patients (76.9%) received immunohistochemistry (IHC) for mismatch repair proteins, and there was no difference in receipt of IHC by race/ethnicity. However, a lower proportion of Black patients were referred to genetic counseling (50.0% vs White patients 54.1% vs Hispanic patients 65.9%; P = .02) and attended genetic counseling appointments (61.2% vs 81.7% White patients vs 86.2% Hispanic patients; P < .01). Of 141 patients receiving genetic testing, 38 (27.0%) had a pathogenic or likely pathogenic variant in a cancer susceptibility gene. An additional 33 patients (23.4%) had variants of uncertain significance, of which 84.8% occurred in racial/ethnic minorities. CONCLUSIONS: In a diverse population of patients diagnosed with young-onset CRC, we observed racial/ethnic differences in referral to and receipt of germline genetic testing. Our findings underscore the importance of universal genetic testing to address racial/ethnic disparities in young-onset CRC.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Dharwadkar P, Greenan G, Stoffel EM, et al. Racial and Ethnic Disparities in Germline Genetic Testing of Patients With Young-Onset Colorectal Cancer. Clin Gastroenterol Hepatol. 2020. PMID: 33359728. doi:10.1016/j.cgh.2020.12.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。